Status | Study |
RECRUITING |
Study Name: Janus Kinase Inhibition in Granuloma Annulare Condition: Granuloma Annulare Date: 2022-12-06 Interventions: Abrocitinib (Cibinqo) is FDA approved at 200 mg dose once daily for the treatment of atopic dermatitis.It is not currently FDA approved for the |
Completed |
Study Name: Evaluation of 41 Cases of Pediatric Granuloma Annulare Condition: Granuloma Annulare Date: 2022-07-15 Interventions: Not Provided |
Completed |
Study Name: Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy Condition: Granuloma Annulare Date: 2008-07-21 |
Terminated |
Study Name: UVA1 Light for Scleroderma and Similar Conditions Condition: Keloid Scleroderma Scars Date: 2007-05-18 Interventions: Device: German manufactured UVA1 emitting light system The dose and scheduling of irradiation is as foll |
Completed |
Study Name: Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix Condition: Keloid Scleroderma, Localized Acne Keloidalis Date: 2005-08-09 Interventions: Procedure: UVB Irradiation A dose of up to 320 mJ/cm2 from a UVB irradiation device will be administered |